…
McPherson's Limited operates as a health and beauty company in Australia, New Zealand, Asia, and internationally. The company offers beauty care; hair care; skin care; footwear; vitamins and supplements; fragrance and nutrition products; and personal care items, including facial wipes, cotton pads, and foot comfort products. It sells its products under the A'kin, Dr. LeWinn's, Lady Jayne, Manicare, Glam by Manicare, Swisspers, Revitanail, Maseur, Footcare by Maseur, Fusion Health, and Bondi brand names. The company was founded in 1860 and is headquartered in Sydney, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
McPhersons Ltd is an Australian consumer goods company that markets and distributes health, beauty and household products through retail and online channels domestically and in selected export markets. Long-term growth may come from rising demand for self-care, e-commerce expansion and distribution partnerships, offering investors exposure to established consumer brands and recurring retail demand.
Principal risks are intense competition from global and private-label players, reliance on a limited set of retail partners and suppliers, and vulnerability to supply-chain, currency and execution challenges that could weigh on sales and margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -25.67M | -19.67M | -12.74M | -4.67M | 0.44M |
| Net income | -20.26M | -15.04M | -15.99M | -5.06M | 0.33M |
| Selling general administrative | - | 41.07M | 35.86M | 39.32M | 39.60M |
| Selling and marketing expenses | - | 27.69M | 26.96M | 32.25M | 29.18M |
| Gross profit | 39.72M | 80.45M | 35.09M | 103.07M | 90.80M |
| Reconciled depreciation | - | 6.55M | 5.91M | 5.99M | 5.67M |
| Ebit | -4.85M | -10.05M | -10.83M | 8.58M | 1.61M |
| Ebitda | -0.66M | -6.99M | -4.92M | 14.56M | 7.29M |
| Depreciation and amortization | 4.19M | 3.07M | 5.91M | 5.99M | 5.67M |
| Operating income | -4.85M | -10.07M | -8.18M | 8.55M | 1.03M |
| Other operating expenses | 123.16M | 157.97M | 152.80M | 0.96M | 33.71M |
| Interest expense | 0.46M | 0.95M | 1.91M | 1.79M | 1.18M |
| Tax provision | - | -3.07M | -1.35M | 0.39M | 0.10M |
| Interest income | - | 0.25M | 0.08M | 0.02M | 0.03M |
| Net interest income | - | -0.70M | -1.83M | -1.76M | -1.14M |
| Extraordinary items | - | 1.56M | -4.61M | - | - |
| Income tax expense | -5.41M | 3.07M | -1.35M | 0.39M | 0.10M |
| Total revenue | 118.31M | 138.99M | 144.62M | 210.26M | 214.00M |
| Total operating expenses | 44.56M | 99.43M | 43.26M | 94.58M | 89.92M |
| Cost of revenue | 78.59M | 58.54M | 109.54M | 107.19M | 123.20M |
| Total other income expense net | -20.82M | -9.60M | -4.56M | -11.40M | 0.70M |
| Net income from continuing ops | - | -16.60M | -11.39M | -5.06M | 0.33M |
| Net income applicable to common shares | - | -15.04M | -15.99M | -5.06M | 0.33M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 96.91M | 117.21M | 146.90M | 187.20M | 212.03M |
| Intangible assets | 20.46M | 27.15M | - | 45.09M | 56.82M |
| Other current assets | 1.32M | 0.96M | 0.82M | 0.99M | 0.85M |
| Total liab | 45.14M | 44.23M | 57.26M | 77.75M | 91.23M |
| Total stockholder equity | 51.77M | 72.98M | 89.64M | 109.45M | 120.81M |
| Other current liab | 9.81M | - | 13.26M | 33.83M | 45.27M |
| Common stock | 216.39M | - | 217.22M | 217.22M | 207.24M |
| Capital stock | - | 217.22M | - | 217.22M | 207.24M |
| Retained earnings | -167.41M | -147.15M | -126.11M | -105.80M | -94.98M |
| Other liab | - | - | - | 9.73M | 10.68M |
| Good will | 3.99M | 19.02M | 23.73M | 33.73M | 33.64M |
| Other assets | - | - | - | 7.59M | 9.12M |
| Cash | 5.11M | 9.48M | 24.77M | 7.03M | 13.14M |
| Total current liabilities | 41.82M | 37.79M | 46.73M | 47.23M | 69.62M |
| Current deferred revenue | 20.88M | - | 12.37M | -4.66M | -18.46M |
| Net debt | 1.08M | - | -5.13M | 18.42M | 16.24M |
| Short term debt | 3.25M | - | 14.07M | 4.66M | 18.46M |
| Short long term debt | - | 0.66M | - | 0.93M | 14.89M |
| Short long term debt total | 6.19M | - | 19.64M | 25.45M | 29.38M |
| Other stockholder equity | - | - | - | -111.42M | -112.26M |
| Property plant equipment | - | - | - | 18.11M | 19.68M |
| Total current assets | 63.15M | 60.65M | 75.78M | 82.68M | 92.77M |
| Net tangible assets | - | - | - | 30.64M | 30.34M |
| Short term investments | - | - | - | - | 0.36M |
| Net receivables | 30.50M | 25.89M | 24.53M | 28.89M | 29.76M |
| Long term debt | - | - | - | 12.59M | 0.00M |
| Inventory | 26.22M | 19.79M | 25.66M | 45.16M | 45.54M |
| Accounts payable | 7.88M | 6.01M | 7.03M | 13.39M | 24.35M |
| Accumulated other comprehensive income | 2.79M | - | -1.47M | -1.97M | 8.54M |
| Non currrent assets other | - | 1.01M | 32.92M | 7.59M | 8.85M |
| Non current assets total | 33.76M | 56.56M | 71.12M | 104.52M | 119.27M |
| Capital lease obligations | - | 6.64M | - | 11.93M | 14.49M |
| Long term debt total | - | - | - | 20.79M | 10.92M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -3.62M | 16.29M | -1.85M | -2.25M |
| Change to liabilities | - | - | - | -9.25M | 1.56M |
| Total cashflows from investing activities | -1.29M | -3.62M | 16.29M | -1.85M | -2.25M |
| Net borrowings | - | -10.20M | -3.04M | -5.15M | -4.80M |
| Total cash from financing activities | -3.78M | -13.91M | -10.90M | -10.91M | -10.59M |
| Change to operating activities | - | - | - | -0.49M | 0.25M |
| Net income | -20.26M | -15.04M | -15.99M | -5.06M | 0.33M |
| Change in cash | -4.37M | -15.29M | 17.74M | -6.11M | 5.79M |
| Begin period cash flow | 9.48M | 24.77M | 7.03M | 13.14M | 7.35M |
| End period cash flow | 5.11M | 9.48M | 24.77M | 7.03M | 13.14M |
| Total cash from operating activities | 0.68M | 2.21M | 12.34M | 6.55M | 18.57M |
| Depreciation | 4.19M | 6.55M | 5.91M | 5.99M | 5.67M |
| Other cashflows from investing activities | - | -2.98M | 17.43M | - | - |
| Dividends paid | - | 0.00M | -4.32M | -5.76M | -5.79M |
| Change to inventory | -6.42M | 6.24M | 10.46M | 0.43M | 2.49M |
| Change to account receivables | 1.55M | -5.14M | 4.81M | 0.77M | 7.83M |
| Sale purchase of stock | -0.81M | - | - | -0.00M | -0.00M |
| Other cashflows from financing activities | -2.90M | -10.20M | -3.54M | -3.78M | -3.92M |
| Change to netincome | - | - | - | 12.47M | 0.54M |
| Capital expenditures | 0.72M | 0.64M | 2.71M | 1.85M | 2.25M |
| Change in working capital | -5.53M | -0.64M | 13.87M | 1.20M | 10.32M |
| Stock based compensation | - | -0.40M | 0.54M | -0.10M | 0.38M |
| Other non cash items | 22.28M | 11.73M | 8.02M | 5.62M | 12.57M |
| Free cash flow | -0.05M | 1.57M | 9.64M | 4.70M | 16.32M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MCP Mcphersons Ltd |
- -% |
0.13 | - | 16.08 | 0.16 | 0.36 | 0.17 | 16.32 |
| S66 Star Combo Pharma Ltd |
-0.04 20.00% |
0.14 | - | - | 0.80 | 0.61 | 0.42 | 4.45 |
| ZNO ZOONO Group Ltd |
-0.00 5.00% |
0.04 | - | 8.88 | 9.73 | 5.76 | 11.89 | -1.38 |
| SKN Skin Elements Ltd |
- -% |
0.00 | - | - | 30.26 | 8.04 | 27.95 | -0.22 |
| AN1 Anagenics Ltd |
0.00 20.00% |
0.01 | - | 4.97 | 0.95 | 1.17 | 1.14 | 7.77 |
McPherson's Limited operates as a health and beauty company in Australia, New Zealand, Asia, and internationally. The company offers beauty care; hair care; skin care; footwear; vitamins and supplements; fragrance and nutrition products; and personal care items, including facial wipes, cotton pads, and foot comfort products. It sells its products under the A'kin, Dr. LeWinn's, Lady Jayne, Manicare, Glam by Manicare, Swisspers, Revitanail, Maseur, Footcare by Maseur, Fusion Health, and Bondi brand names. The company was founded in 1860 and is headquartered in Sydney, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Grant W. Peck C.A. | MD, CEO & Director | NA |
| Mr. Paul Witheridge B.Com, B.Com., C.A., CA | CFO & Joint Company Sec. | NA |
| Ms. Lori Pirozzi | National Accounts Director | NA |
| Donna Chan | Marketing Director | NA |
| Ms. Lisa Sheehan | Chief People Officer | NA |
| Mr. Philip R. Bennett BCom, CA | Joint Company Sec. | NA |
| Mr. Sammy K. S. Chan | Managing Director of McPherson's Hong Kong Limited | NA |
| David Fielding | Director of Strategy, Planning and Innovation | NA |
| Mary Pearce | R&D Director | NA |
| Dawn Swainston | Gen. Mang. of Health | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.